glp 1 drugs contraindications Researchers find GLP-1 medications safe to continue before surgery in patients with diabetes and obesity GLP-1 Therapy Part 1: Setting

Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hnselmann A, Nilsson B, Mller JE, Hjort J, Rasmussen J

Key Points Native human GLP-1 normalizes hyperglycaemia in patients with type 2 diabetes mellitus, but the short in vivo half-life of this hormone limits its therapeutic application A number of synthetic GLP-1 receptor agonists, with half-lives between 23 h and several days, have been developed for the long-term treatment of type 2 diabetes mellitus Short-acting GLP-1 receptor agonists (such as exenatide and lixisenatide) predominantly lower postprandial glucose levels and insulin concentrations via retardation of gastric emptying Long-acting GLP-1 receptor agonists (such as albiglutide, dulaglutide, exenatide long-acting release and liraglutide) predominantly lower blood glucose levels through stimulation of insulin secretion and reduction of glucagon levels Adverse effects of GLP-1 receptor agonists include nausea, vomiting and diarrhoea, injection-site reactions, antibody formation and increased heart rate This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access 176,64 per year only 14,72 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

Visceral fat is metabolically active and releases inflammatory signals that influence insulin resistance and cardiovascular risk

Once your plan is customized, you will follow a simple routine that fits your lifestyle

Breastfeeding itself This sounds reductive, but it is evidence-based

Adverse effects such as nausea, vomiting, and gastrointestinal discomfort remain common, but usually diminish with time and proper dose escalation